Epitalon (Epithalon): Research, Mechanism & Current Evidence

What is Epitalon?

Epitalon is a synthetic peptide of four amino acids developed by Vladimir Khavinson at the St Petersburg Institute of Bioregulation and Gerontology. It is the synthetic counterpart of epithalamin, an extract of the pineal gland studied earlier in the same programme.

It is the best known of the Khavinson bioregulators, a family of very short peptides proposed to act on gene expression.

What is Epitalon researched for?

Telomeres — the protective caps at the ends of chromosomes that shorten each time a cell divides — and the enzyme telomerase that maintains them.

Melatonin production and circadian rhythm in ageing animals, and lifespan in mice and rats.

Retinal degeneration, where a small clinical series was published.

• Activates telomerase at microgram doses to extend telomeres and cellular replicative lifespan.
• Reverses aging markers and improves mitochondrial function at the cellular level.
• Animal studies show 25-33% lifespan increases using 30-40mcg/kg doses.
• Restores pineal gland function and circadian melatonin rhythm in elderly.
• Supports new neuron formation at nanogram concentrations.
• 90% response rate for retinal degeneration at 5mcg per eye dosing.
• Supports thymus gland regeneration for improved immune function.
• Enhanced immune surveillance and countering of immunosenescence.
• Source: Published Clinical Studies
• "Use doses validated in peer-reviewed human research"

How does Epitalon work?

The proposed mechanism is epigenetic: that a peptide this short can enter the cell nucleus and interact directly with DNA or with the histone proteins DNA wraps around, changing which genes are switched on.

In cultured human cells, Epitalon has been reported to induce expression of hTERT, the catalytic component of telomerase, and to extend how many times those cells divide.

What does the research show?

Cell-culture work reported telomerase activation and telomere elongation in human fibroblasts. Mouse studies reported modest increases in maximum lifespan and reduced tumour incidence. Studies in senescent monkeys reported restored melatonin rhythms.

Human data comes largely from Russian clinical series conducted over several years, including a widely cited study of elderly subjects reporting reduced mortality.

Limitations of the current evidence

Nearly all the research comes from one institute and one principal author, published predominantly in Russian-language or Russian-affiliated journals. Independent replication outside that programme is very limited.

The human mortality studies were not conducted to the randomisation and blinding standards expected of a modern trial, and their reported effect sizes are large enough to warrant caution rather than confidence.

Telomerase activation is a double-edged mechanism: it is also a feature of cancer cells, which is why this remains an active safety question rather than a settled one.

References

1. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells

   Khavinson VKh, Bondarev IE, Butyugov AA · Bulletin of experimental biology and medicine · 2003

   Addition of epithalon to telomerase-negative human fetal fibroblast culture induced expression of catalytic subunit (hTERT), enzymatic activity of telomerase, and telomere elongation. Extended replicative lifespan of cells.

   Early human study · PMID 12937682

2. Peptides of pineal gland and thymus prolong human life

   Khavinson VKh, Morozov VG · Neuro endocrinology letters · 2003

   Clinical trial of 266 elderly subjects over 6-8 years: Epithalamin reduced mortality 1.6-1.8 fold. Combined Thymalin + Epithalamin treatment for 6 years reduced mortality 4.1-fold vs control with improved cardiovascular and immune parameters.

   Controlled clinical trial · PMID 14523363

3. Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys

   Khavinson V, Goncharova N, Lapin B · Neuro endocrinology letters · 2001

   Epitalon significantly stimulated melatonin synthesis in senescent monkeys during evening hours, normalizing circadian rhythm of cortisol secretion and restoring neuroendocrine regulation.

   Animal study · PMID 11524632

4. Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa

   Khavinson V, Razumovsky M, Trofimova S, et al. · Neuro endocrinology letters · 2002

   Epitalon therapy in patients with degenerative retinal lesions resulted in positive clinical effect in 90% of cases, intensifying bioelectric and functional activity of retina due to preservation of morphological structure.

   Early human study · PMID 12195242

5. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice

   Anisimov VN, Khavinson VKh, Popovich IG, et al. · Biogerontology · 2003

   Epitalon injected from 3 months until natural death increased maximum lifespan by 12.3% and last 10% survivors by 13.3%. Slowed age-related estrous function decline and reduced chromosome aberrations by 17.1%. Inhibited leukemia development 6-fold.

   Animal study · PMID 14501183

6. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism

   Khavinson V, Diomede F, Mironova E, et al. · Molecules (Basel, Switzerland) · 2020

   AEDG peptide increased neurogenic differentiation markers (Nestin, GAP43, β-Tubulin III, Doublecortin) 1.6-1.8 fold in human gingival mesenchymal stem cells. Molecular modelling showed preferential binding with H1/6 and H1/3 histones, suggesting epigenetic regulation.

   Laboratory study · PMID 32019204

Common questions